News
Joie Armstrong asked her doctor about taking a GLP-1 medication to help her lose weight six times before she got a prescription, and then was denied coverage by her insurance company. Adrian, a ...
Weight-Loss Drug Shortages: Access Now Limited to Diabetes Medication Mounjaro (tirzepatide) Written by Dan Gray on December 9, 2022 — Fact checked by Dana K. Cassell ...
Semaglutide and tirzepatide prescriptions for obesity are influenced by race, gender, social vulnerability, and urbanicity, with disparities in access and utilization. Despite increased ...
Amid the surge in demand, Eli Lilly and pharmacies have started to tighten access to the latest of this type of drug, tirzepatide, focusing on giving it to people with type 2 diabetes, the only ...
Hydreight Technologies announced the addition of Tirzepatide to its weight loss portfolio which also includes GLP-1 injections, giving patients a cost-effective way to access safe, high quality ...
INDIANAPOLIS – The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs were taken off the FDA’s shortage list.
If tirzepatide remains off the FDA's drug shortage list, compounding pharmacies must cease the production of these medications on any significant scale, according to gastroenterologist and obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results